United States:
FDA Issues Emergency Use Authorization For In Vitro Diagnostic Device For Detection Of Ebola Zaire Virus
28 September 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the September 14, 2015, Federal Register, FDA
announced the issuance of an Emergency Use Authorization
("EUA") for an in vitro diagnostic device for the
detection of the Ebola Zaire virus in response to the recent
outbreak in West Africa. FDA issued this EUA pursuant to the
Federal Food, Drug, and Cosmetic Act ("FDCA") at the
request of the applicant. Effective July 31,
2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
